Cart is empty 
Plenty of compounds/peptides build muscle by boosting natural growth hormone. SLU-PP-332 does something quite different. Like most synthetic compounds, it has a direct natural analogue, but it’s one you’ll never see coming if you haven’t heard of SLU-PP-332 (you can buy SLU-PP-332 here) before. Exercise.
SLU-PP-332 triggers the same kinds of metabolic changes you’d usually only see in elite endurance athletes. [1] The rodent studies that proved the concept are some of the most interesting papers you’ll ever read — “couch potato” mice treated with SLU-PP-332 suddenly had the endurance of “colleagues” that researchers had actively subjected to training. All without any changes to their diets or workout regimens. (You can just picture them running 70 percent longer and 40 percent further than before on tiny treadmills, can’t you?)
The research potential absolutely isn’t limited to turning sedentary mice into little roadrunners. When SLU-PP-332 gets to work — by activating so-called estrogen-related receptors, chemical switches for better energy metabolism — it builds instant stamina, boosts fat oxidation, increases mitochondrial density, and pushes muscle fiber composition toward the more fatigue-resistant type.
Some people call SLU-PP-332 “exercise in a bottle,” and that’s fair. It’s obvious why athletes would be interested in an instant stamina builder, but there’s real medical potential, too. The most obvious application? People who can’t move — because they’re stuck in hospital with IV drips and other machinery attached to them — lose muscle shockingly fast. SLU-PP-332 might just change that.
A Very Brief History of SLU-PP-332
Some peptides and similar compounds get discovered quite accidentally, while some research team or another is looking into something completely different. That wasn’t the case with SLU-PP-332. The researchers who created it were very intentional about its design. They wanted to make a compound that targeted estrogen-related receptors, orphan compounds that look a bit like estrogen receptors but are activated by a different, still unknown compound, and they had the goal of developing a new treatment for metabolic disease.
Lots of mystery still surrounds ERRs, but when Dr Thomas Burris and his team got to work on SLU-PP-332, they already knew that ERRs:
- Make new mitochondria
- Encourage the body to burn fat for energy
- Balance cell energy expenditure overall
Unable to find the natural “activation button,” they made one from scratch. That compound is SLU-PP-332 — and so far, studies in mice have proven that it effectively induces weight loss and improves insulin resistance. That’s exciting on its own, but there’s more, of course. By far the most interesting property of SLU-PP-332 is its ability to push muscles into fatigue-resistant mode — to build the kind of slow-twitch oxidative muscle fibers you’d usually only see in marathon runners. Except the mice in the studies hadn’t even so much as trained for a 5 K.
This compound deserves some shameless repetition, so here that is again. SLU-PP-332 is an instant stamina compound in a world full of people who either don’t exercise or actually can’t. For that reason alone, you’ll be seeing it around — because researchers eager to push new discoveries simply can’t leave it alone.
How Does SLU-PP-332 Work?
So, SLU-PP-332 builds endurance in the most sedentary specimens — but how?
SLU-PP-332 hijacks the estrogen-related receptors that work as genetic switches within cells, ERRs α, γ, and δ. Once inside cells, it starts a whole cascade of gene expression, and SLU-PP-332 basically orders cells to reprogram themselves to become super efficient.
Three main things then happen:
- Cells make more mitochondria (you’ve heard it before — “the power house of the cell” and all that) — and cells’ total energy capacity goes up.
- Cells also get told to pick fat, instead of glucose, as their preferred power source. That’s simultaneously more efficient and more fat-burning.
- We already said ERRs rewrite genetic programs, and this part is pretty exciting, too. SLU-PP-332 tells slow-twitch muscle fiber genes to express themselves more. Slow-twitch, also called Type 1, fibers are full of capillaries and mitochondria, and extremely resistant to fatigue. You’ll see them in elite athletes who spend most of their days either training or optimizing their training regimes.
Not a performance enhancer, then (those wear off), but a genetic switch. SLU-PP-332 permanently changes cell behavior — from standard to high-efficiency and optimized for endurance.
Exercise does exactly the same thing, by the way. (No, not the “I sign up for the gym in January and get back to the couch in February” kind, but the “serious athlete” kind.) Except with SLU-PP-332, working out is optional. That’s what makes it so important.
What Applications Has SLU-PP-332 Research Looked at So Far (and What Could Be Next)?
Studies point to the use cases that investigators in the fitness and biohacking communities are most interested in — SLU-PP-332 can “transform fitness and help people lose weight by boosting metabolic pathways and aerobic exercise” as well as opening the door to “therapeutic advantages for metabolic syndrome and its associated disease.” [2]
Let’s not lie; that’s where the current focus is. Researchers haven’t neglected to dip their toes into deeper waters either, however, because the ERRs SLU-PP-332 activates have potential uses in any area where mitochondrial function and energy production have become impaired.
SLU-PP-332, Exercise Mimetics and Metabolic Health
We’ve already told you all about the impact SLU-PP-332 has on endurance — mice treated with the compound can run 70 percent longer, even when they were the mouse equivalent of an office worker doing nothing but sitting at a desk all day. That first study, which proved that the concept worked, has been followed by others [3], and SLU-PP-332 has received widespread coverage in the press [4] for precisely that reason.
Exercise activates a beneficial state that was, until now, impossible to synthetically replicate. SLU-PP-332 has permanently changed that — and there’s no question that researchers will continue to study the best ways to use it to boost stamina in the groups of people who need that kind of support the most.
SLU-PP-332 Applications in Heart Failure and Cardiovascular Health Research
A failing heart works very differently than a healthy one — instead of running on fatty acid oxidation, it shifts to glucose. Very inefficient. Could SLU-PP-332 reprogram that, through its positive impact on muscle structure and mitochondrial building? Research that tries to answer this question is already under way. So far, the conclusion is that SLU-PP-332 “significantly improved ejection fraction, ameliorated fibrosis, and increased survival.”
Good news, but just the beginning. One day, as the researchers behind that study said, SLU-PP-332 could become a “novel class of heart failure treatment.” [5]
What About Sarcopenia and Age-Related Muscle Wasting?
That’s exactly the most obvious use case for SLU-PP-332 — and we’re thrilled to be following the latest developments in this area. One new study, freshly published in 2025, divided women undergoing hip arthroplasty for coxarthrosis into active and sedentary groups. They both had samples taken during surgery. Experiments followed, and the samples treated with SLU-PP-332 showed less cytotoxicity and cell death, less oxidative stress, and higher Glutathione levels. [6]
We’re still a long way off, but the potential is already clear. SLU-PP-332 might well be able to help older people, who naturally lose muscle, hold onto stronger, healthier, muscles. At a basic level, that would give many the opportunity to live independently for longer. The dream, though, is the kind of thing you rarely see now. Being able to run marathons in your 70s.
SLU-PP-332 in Metabolic Disease Research (and Beyond)
Going back to its original purpose, SLU-PP332 has also shown promise in the fields of obesity management and its secondary complications — type 2 diabetes, insulin sensitivity, and more. A 2024 study called SLU-PP-332 an “effective agent for weight loss.” It also, however, noted an indirect positive impact on kidney health. [7]
Then, there’s this — still early days, but very much worth following. One study found that SLU-PP-332 inhibits tumor growth in prostate cancer by targeting ERRs. [8] Other research has investigated the very real possibility that SLU-PP-332 could be developed as a COVID treatment, with a special focus on cases of long COVID — where the symptoms become chronic as patients’ quality of life dwindles.
How Is SLU-PP-332 Administered in Research Settings?
Researchers in the middle of preclinical research choose their route of administration with the goal of achieving two things — consistent delivery (keeps study outcomes reproducible) and systemic delivery (to fully observe the effects). [9]
That’s why intraperitoneal injection has become the most common delivery method for SLU-PP-332. IP injection makes efficient absorption possible in rodent studies. The “vehicle solution” is different than it is for most peptides. SLU-PP-332 is often reconstituted with a mix of DMSO, PEG, and saline. It doesn’t do well with bacteriostatic water, and researchers who try that immediately notice that the mixture gets cloudy or has floating particles.
Research into different delivery methods is also underway. Oral dosing is not unheard of, and sublingual SLU-PP-332 also exists, but it would completely change the bioavailability of the compound. For now, IP injection is the go-to.
How Are SLU-PP-332 Dosing Protocols Calculated?
A consensus doesn’t yet exist around SLU-PP-332 dosing — any new research protocols are usually based on the animal studies already published in peer-reviewed journals. Those are preclinical studies, and no established human dose exists yet.
The most-quoted study, which showed that sedentary mice given SLU-PP-332 could suddenly run for impressive periods of time, used a dose of 10 mg per kilogram of body weight (mg/kg), given via intraperitoneal injection once a day.
Anecdotal reports from biohackers and longevity researchers are also interesting. Many strongly recommend a starting dose of 50 micrograms. That low starting point allows for acclimatization and lets investigators see what the initial results are. After that, researchers with the general goal of building endurance, boosting energy, and muscle preservation report going up to 100 micrograms.
Higher doses are also cited. Common dosing protocols you will see mentioned in various studies include:
- A protocol of 200 to 300 micrograms over two daily doses — for endurance
- 400 micrograms daily to achieve systemic effects, including for weight loss studies
- Even doses of 500 micrograms are sometimes reported, especially among biohackers
Dosing is frequent because of the half life of SLU-PP-332 — it clears from the system after around six hours. Reports of cycling SLU-PP-332 for two weeks and then taking a break of a week or two are not uncommon and has the goal of preventing tolerance.
These preliminary reports can be very interesting to people investigating the compound, but designing studies always comes back to the established literature.
FAQs
n lab settings, researchers mainly research SLU-PP-332 as an exercise mimetic (that is, a compound that makes your body act like you’ve exercised, but without actually working out) and a future treatment for metabolic disease.
Things researchers are interested in are varied — if SLU-PP-332 can facilitate a switch from burning glucose to burning fat, how it can help preserve muscle and build stamina, to what extent it can fight age-related symptoms, and even if SLU-PP-332 can serve as a new heart failure treatment. Reports also indicate that SLU-PP-332 boosts energy.
The studies done so far have shown a favorable side effect profile. In other words, not many are reported. The mice that showed such amazing endurance didn’t have their diets changed, on the other hand, and starting vigorous exercise without increasing calories can reasonably be expected to lead to fatigue and weight loss beyond the stated goal.
To start with (and don’t kick yourself, because this is a common question), SLU-PP-332 isn’t even a peptide at all. It’s a small compound that was engineered to fight metabolic disease. Its mechanism of action is also completely different.
GHS peptides trigger the release of more natural growth hormone, something that leads to faster recovery and easier muscle building. Metabolic peptides (OAD9604, Tesamorelin, etc) induce fat loss. SLU-PP-332 is more of a genetic regulator, and its observed effects amount to metabolic reprogramming for better endurance and smarter energy use.
Scientific References and Sources
- https://pubmed.ncbi.nlm.nih.gov/37739806/[↩]
- https://www.researchgate.net/profile/Bhupendra-Mahale/publication/385096831_Unlocking_the_potential_slu-pp-332_and_the_future_of_exercise_Enhancement_and_Metabolic_health/links/67163cba24a01038d0fa3ea3/Unlocking-the-potential-SLU-PP-332-and-the-future-of-exercise-Enhancement-and-Metabolic-health.pdf[↩]
- https:/pubs.acs.org/doi/abs/10.1021/acschembio.2c00720">((https://pubs.acs.org/doi/abs/10.1021/acschembio.2c00720[↩]
- https://www.medicalnewstoday.com/articles/new-drug-may-help-lose-weight-reduce-fat-by-mimicking-exercise[↩]
- https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.123.066542[↩]
- https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2025.1616693/full[↩]
- https://jrenendo.com/Article/jre-25143[↩]
- https://pubs.acs.org/doi/abs/10.1021/acschembio.0c00670[↩]
- https://www.sciencedirect.com/science/article/pii/S0306987724001051[↩]
